Waddell & Associates, LLC Eli Lilly & CO Transaction History

Waddell & Associates, LLC

$815 Million
Q3 2024

A detailed history of Waddell & Associates, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Waddell & Associates, LLC holds 6,142 shares of LLY stock, worth $4.72 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

6,142

Previous 6,150 0.13%

Holding current value

$4.72 Million

Previous $5.57 Million 2.28%

% of portfolio

0.67%

Previous 0.74%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $6,177 - $7,680	-8 Reduced 0.13%	6,142 $5.44 Million
Q2 2024 Aug 06, 2024	BUY	$724.87 - $909.04 $7,248 - $9,090	10 Added 0.16%	6,150 $5.57 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $260,568 - $348,603	440 Added 7.72%	6,140 $4.78 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $488,951 - $576,410	-931 Reduced 14.04%	5,700 $3.32 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $10,867 - $14,982	-25 Reduced 0.38%	6,631 $3.56 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $229,734 - $307,181	655 Added 10.91%	6,656 $3.12 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $16,463 - $19,335	-53 Reduced 0.88%	6,001 $2.06 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $1,286 - $1,498	-4 Reduced 0.07%	6,054 $2.21 Million
Q2 2022 Jul 27, 2022	BUY	$278.73 - $327.27 $55,188 - $64,799	198 Added 3.38%	6,058 $1.96 Million
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $147,726 - $183,329	657 Added 12.63%	5,860 $1.62 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $5.22 Million - $6.42 Million	-23,540 Reduced 81.9%	5,203 $1.2 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $5.19 Million - $6.71 Million	28,743 New	28,743 $1.13 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waddell & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waddell & Associates, LLC with notifications on news.

Account

Waddell & Associates, LLC Eli Lilly & CO Transaction History